Δ8(14)-Ergostenol Glycoside Derivatives Inhibit the Expression of Inflammatory Mediators and Matrix Metalloproteinase

Autor: Dowon Yoon, Hakwon Kim, Yujin Park, Tae Hoon Lee, Myoungsil Ko, Eunjoohwang Lee, Jeonguk Kim, Hye-Jin Moon
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Interleukin-1beta
Anti-Inflammatory Agents
Nitric Oxide Synthase Type II
Pharmaceutical Science
Arthritis
Organic chemistry
Pharmacology
Matrix metalloproteinase
Analytical Chemistry
chemistry.chemical_compound
0302 clinical medicine
QD241-441
Ergosterol
Drug Discovery
Glycosides
chemistry.chemical_classification
0303 health sciences
Communication
collagen type II A1
Synoviocytes
ergostenol
arthritis
Chemistry (miscellaneous)
Molecular Medicine
medicine.symptom
Signal Transduction
matrix metalloproteinase
Cell Survival
Inflammation
Chronic inflammatory disease
Models
Biological

Cell Line
03 medical and health sciences
Chondrocytes
medicine
Humans
ergostenol glycosides
Physical and Theoretical Chemistry
Collagen Type II
030304 developmental biology
030203 arthritis & rheumatology
Collagen type
Interleukin-6
Tumor Necrosis Factor-alpha
Interleukin-8
Glycoside
medicine.disease
Matrix Metalloproteinases
Sterol
Spinasterol
Gene Expression Regulation
chemistry
Zdroj: Molecules, Vol 26, Iss 4547, p 4547 (2021)
Molecules
ISSN: 1420-3049
Popis: Arthritis is a chronic inflammatory disease accompanied by pathological reactions such as swelling, redness, fever, and pain in various joint areas. The drugs currently available to treat arthritis are associated with diverse side-effects. Therefore, there is a need for safer and more effective treatments to alleviate the inflammation of arthritis with fewer side-effects. In this study, a new sterol, Δ8(14)-ergostenol, was discovered, and its glycosides were synthesized and found to be more efficient in terms of synthesis or anti-inflammatory activity than either spinasterol or 5,6-dihydroergosterol is. Among these synthetic glycosides, galactosyl ergostenol inhibited the expression of inflammatory mediators in TNF-α-stimulated FLS and TNF-α-induced MMPs and collagen type II A1 degradation in human chondrocytes. These results suggest the new galactosyl ergostenol as a treatment candidate for arthritis.
Databáze: OpenAIRE